- Life Sciences
- Conference
Biomarkers & Precision Medicine US 2025
Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to attend the Biomarkers & Precision Medicine US 2025 and present how Tempus can help you accelerate biomarker discovery by leveraging our end-to-end spatial services and licensable multimodal data library.
Uncovering spatial biomarkers that differentiate responders in NSCLC and CRC with Integrated Visium HD Data: A case study with AstraZeneca
Learn about Tempus’ protocol for generating high-quality spatial transcriptomic data from a real-world clinical next-generation sequencing pipeline and our Visium HD service capabilities. Explore how we pair spatial data with our licensable real-world data cohorts and associate spatial features with biomarkers from bulk DNA, RNA, and H&E, such as our Immune Profile Score. Review a case study with AstraZeneca that demonstrates how spatial features can identify slow progressors to immunotherapies beyond traditional biomarkers. Add to calendar
Location Conference Room 4 Speakers Shing Shing Ho, Associate Director, Machine Learning (Tempus) Arjun Ishwar, Solutions Director, Omics (Tempus)
Schedule a meeting with us
We'll be in touch shortly.